Arcutis Biotherapeutics, Inc. (ARQT)
ARQT price $32.10 +0.23 +0.72%
- Ticker
- ARQT
- Price
- $32.10
- Change
- +0.23 +0.72%
- Market cap
- $4.03B
- P/E
- 148.64
- Forward P/E
- 66.19
- Sector
- Healthcare
- Industry
- Biotechnology
- Stocklytics score
- 54
Arcutis Biotherapeutics, Inc. is a biopharmaceutical firm dedicated to developing and marketing therapies for a range of skin-related diseases. The company's flagship investigational compound, ARQ-151, a roflumilast cream administered topically, has successfully concluded late-stage clinical development for treating both plaque psoriasis and atopic dermatitis. Beyond its lead asset, Arcutis's pipeline includes…